Schedule I drugs are considered to have a high potential for abuse with no currently accepted medical use. The category includes drugs such as heroin and LSD. Schedule III drugs are defined as having low risk for psychological or physical dependence. Schedule III drugs include Tylenol with codeine, ketamine and anabolic steroids, according to the DEA’s website.
Stocks getting a boost from the news were Tilray (NASDAQ:TLRY), Canopy Growth (NASDAQ:CGC), Aurora Cannabis (ACB), Cronos (CRON), Village Farms (VFF), Curaleaf (OTCPK:CURLF), SNDL (SNDL) and Medical Marijuana (OTCPK:MJNA).
